Drug Profile
Herpes simplex vaccine - AuRx
Alternative Names: HSV-2Latest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator AuRx
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 29 Sep 2015 No recent reports on development identified - Phase-I/II for Herpes simplex virus infections in Mexico (Intradermal)
- 28 Nov 2002 Follow up data from a media release have been added to the Viral Infections therapeutic trials section
- 15 Nov 2002 A study has been added to the adverse events and Viral Infections therapeutic trials section